U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07533799) titled 'The Swedish BioFINDER Sleep Study' on April 01.
Brief Summary: BioFINDER-Sleep study was established in 2021 and will include patients with early Parkinson's disease (PD) and persons with iRBD to provide essential insights into the underlying mechanisms of the progressive neurodegenerative processes in central and peripheral nervous systems. Briefly polysomnography will be used to establish the presence of RBD in both the early PD cohort and in the iRBD cohort. Then, state of the art multimodal imaging techniques will be used, including, magnetic resonance imaging (MRI), positron emission tomography (PET) of the dopamine transporte...